Dr. Bernd Goergen
Partner at HTGF
About
Dr. Bernd Goergen, a PhD virologist and immunologist, combines hands-on hepatitis expertise and certified biotech-analyst training with over a decade of seed investing and led the MYR hepatitis D exit.
Invests in
BiotechClimate TechDeep TechHardwareMedical DevicesSaaS